The American Society for Cell Biology (ASCB) advocates for policies that support scientific research and the cell biology community. Through official letters, comments, testimony, and other communications, ASCB shares its positions and recommendations with policymakers, federal agencies, and other organizations on issues affecting biomedical research and the scientific enterprise.
- ASCB Joins Others in Asking Congress to Stop White House Funding Changes
- ASCB Submits Comments Opposing White House Science Changes
- ASCB Submits Comments Opposing Reduced Terms for F and J Visas
- ASCB, 500 Groups Express Concern About White House’s Proposed NIH Budget
- ASCB Joins Over 500 Organizations Calling for 9% Increase for FY26 NIH Budget
- ASCB Joins Other Groups in Praising Work of Scientists
- ASCB joins over 200 other organizations to urge Congress to protect federally funded data on agency websites
- ASCB, Others Call for “Robust” NIH Funding
- ASCB Thanks Senate for Proposed Fix to Visa Interview Delays
- ASCB Letter to Sen. Cassidy on How the NIH can be Modernized and Improved
- ASCB Comments on NIH Proposed Simplified Review Framework for Research Project Grant Applications
- ASCB Asks President Biden to Address Major Delays Obtaining Visas to Enter U.S.
- ASCB Asks President to Provide Important Visa Protections for STEM Trainees from Ukraine Studying in the U.S.
- ASCB Supports Bill to Offer Green Cards to US-Trained International Trainees
- ASCB / GSA Letter to NIH regarding Model Organism Databases (MODs)
- ASCB Joins Call on President-elect Biden to Rescind Trump Fetal Tissue Restrictions
- ASCB Comments on Dept. Homeland Security proposal to establish fixed time periods for student visas
- ASCB Expresses Concern Over Changes to NSF GRFP Program
- ASCB, 80 Others Urge Agencies to Follow Science in COVID Decisions
- Cell Biology Supports NASEM Study of Structural Racism in Academia
- Medical Research Community Asks for Research Funding to be Included in COVID Relief Bills
- ASCB, Others Call For Repeal of Student Visa Policy Change
- ASCB Seeks Visa Extensions Due to COVID-19 Closures
- ASCB One of 92 Groups Opposing Trump Administration Ban on Fetal Tissue Research
- ASCB Joins 67 Groups Supporting Amendment to Block Fetal Tissue Ban
For more information on these and other policy issues, contact Kevin Wilson, ASCB’s Vice President, Policy, Governance and Partnerships. The ASCB has “Be an Advocate for Science” how-to papers to help you be an advocate for science.